MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with Z

Zinc acetate

Zinc acetate 25mg capsules

Incompatible

Stability notes for Zinc acetate 25mg capsules

Store in nonmetallic, airtight containers.

Provenance

This compatibility recommendation is derived from Wilzin 25mg capsules (Recordati Rare Diseases UK Ltd).

Supplier

Wilzin 25mg capsules (Recordati Rare Diseases UK Ltd)

Zinc acetate 50mg capsules

Incompatible

Stability notes for Zinc acetate 50mg capsules

Store in nonmetallic, airtight containers.

Provenance

This compatibility recommendation is derived from Wilzin 50mg capsules (Recordati Rare Diseases UK Ltd).

Supplier

Wilzin 50mg capsules (Recordati Rare Diseases UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.